1 / 30

Local Anesthetics LA

Local Anesthetics LA. Prepared by : Dr Alia Alshanawani College of Medicine, KSU. LA: Reversibly block impulse conduction along nerve axons & other excitable membrane that utilize Na + channels for Action Potential generation.

tuan
Download Presentation

Local Anesthetics LA

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Local Anesthetics LA Prepared by : Dr Alia Alshanawani College of Medicine, KSU.

  2. LA: Reversibly block impulse conduction along nerve axons & other excitable membrane that utilize Na+ channels for Action Potential generation. Uses: block pain sensation (nociception) from specific area of ! body. Cocaine was ! 1st LA isolated from Coca plant as an ophthalmic anesthetic; Its chronic use: psychological dependence (addiction).

  3. Followed by procaine & then Lidocaine (Lid) which is ! most widely used LA. What characteristics of LAs make them ideal agents for anesthesia? As ropivacaine 1- Rapid/ faster onset, 2- Long Duration of Action, 3- Reversible & selective blockade of sensory nerves without motor blockade, 4- Minimal local tissue irritation & no systemic toxicities (cardiac & CNS).

  4. Weak base & available as salts to increase solubility & stability. Consist of lipophilic gp (aromatic ring): memb penetration ++ intermediate chain via an ester or amide to ionizable gp: for channel blockade . Chemistry of LA

  5. •Absorption of injected LA, esp systemic: depends on: 1- dosage, 2- site of inj, (VASCULARITY): IV > tracheal > intercostals > paracervical > epidural > brachial plexus > sciatic > SC 3- drug-tissue binding, 4- local blood flow, 5- use of Vasoconstrictors (epinephrine/ phenylephrine) & 6- ! physiochemical property of ! drug. Absorption in highly vascular area (trachea, intercostal) is > poor perfused tissues (dermis & SC fat).

  6. Epinephrine/ VC: Slow ! removal & reduce systemic absorption of LA from inj site by decreasing blood flow (upto 30%) & cause higher local tissue conc. of ! drug & prolong conduction blockade. + reduce CNS & systemic tox. Used with short/ intermediate duration of action: (procaine, Lid & mepivacaine). VCs are < effective in prolonging anesthetic action of more lipid-soluble, long-acting drugs (bupivacaine & ropivacaine) which are highly tissue-bound.

  7. Distribution ! Amide LAs are widely distributed after IV bolus inj. Initial rapid phase into highly perfused organs (brain, kidney, liver & heart), then a slower phase to moderately perfused organs (Muscle, GIT).

  8. Acidification of urine: ionization & excretion of LA Ester-type hydrolyzed rapidly in ! blood (by pseudo-choline-sterase) to inactive metabolites; short plasma t1/2 (< 1 min). ! amide linkage is hydrolyzed by liver cytochrome P450 with different rates order (prilocaine (fastest) > Lid > bupivacaine (slowest). All ester & amide LAs converted to more water-soluble metabolites & excreted in urine. Metabolism & Excretion

  9. Toxicity from amide-type LA occur in hepatic D. Ex: elimination t1/2 of Lid increase from 1.6 hr in normal pat to > 6 hr in liver disease pat. amide LA also affected by enz inhibitors. Reduced hepatic bld flow: decrease their elimination.

  10. Block ! Initiation & propagation of action potential (AP) by preventing voltage-gated Na+ channels. Activity is PH-dependent, increased at alkaline PH. Its penetration to Na+ channels is very poor at acid PH. Inflamed tissues (acidic): resistance to LA. Elevated extracellular Ca2+ antagonizes ! action of LA by Ca2+ which increase ! surface potential on ! membrane. MOA

  11. Smaller & more lipophilic LA: ! Faster rate of interaction with Na+ channels. Potency is +vely correlated with lipid solubility. Lid, procaine, & mepivacaine are > water-soluble than tetracaine, bupivacaine, & ropivacaine that are > potent & have longer DOA. Long acting (bupivacaine ) also bind more extensively to plasma proteins & can be displaced by other protein-bound drugs. Structure- Activity Characteristics of LA:

  12. Other actions of LA on nerves: 1- Loss of sensation from site of painful stimuli 2- Motor paralysis during surgery; desirable; but also limit ! ability of patient to cooperate in obstetric delivery. Disadvantages In Spinal anesthesia, motor paralysis: impair respiratory activity & AN blockade: hypotension & urinary retention (catheterization).

  13. 1- Effect on fiber diameter: LA block conduction in small-diameter nerve fibers > readily than in large fibers. (bec electrical impulse is shorter) Pain sensation is blocked > readily than other sensory modalities. Motor axons (large diameter), are relatively resistance. LAs block conduction in ! following order: smallmyelinated (pain impulses), non- myelinated (C-fibers), large myelinated axons.

  14. 2- Effect on firing frequency Blockade by LA is > at higher frequencies of depolarization. Sensory (esp pain) fibers have High firing rate & long AP duration. while Motor fibers fire at a slower rate & have shorter AP duration.

  15. Properties of LAs

  16. Surface/topical anesthesia Local infiltration Peripheral nerve block Bier block (IV regional anesthesia) Epidural anesthesia Spinal anesthesia (subarachnoid) Methods of administration: Six Placement Sites

  17. Epidural Spinal

  18. Effective analgesia in specific regions of ! body. Route of administration: 1- Topical/ surface application (nasal mucosa, wound margins) 2-Inj in ! vicinity of peripheral nerve endings (infiltration) & major nerve trunks (blocks) 3- Inj into ! epidural or subarachnoid spaces surrounding ! spinal cord. 4- IV regional anesthesia (Bier block) for surgery < 60 min in limbs. Clinical pharm

  19. Short: proc- & chloropro- caine Intermediate: Lid, mepiva- & prilo- caine Long-acting: tetra-, bupiva-, & ropiva- caine. duration can be prolonged by increasing ! Dose/ adding VC agent. Duration of Action

  20. To increase onset of LA: + Na-bicarbonate to LA sol; LA become > lipid soluble. Repeated inj of LA: tachyphylaxis (extracellular acidosis) Pregnancy increase LA tox. Topical LA: eye, ENT & for cosmetic surgery. Properties: 1- rapid penetration across ! skin/ mucosa & 2- low tendency to diffuse away from ! site of application. Cocaine bec of excellent penetration & local VC used for (ENT) procedures. Has irritating effect so NOT used in ophthalmic procedure. Other topical: Lid + VC, tetracaine, dibucaine, benzocaine, & dyclonine.

  21. OTHER USES: LAs have membrane-stabilizing effects; Both IV Lid & po (mexiletine, tocainide) used to Tr patients with neuropathic pain syndrome: (uncontrolled, rapid, sensory fiber firing). Systemic LA: as adjuncts to TCA (amitriptyline) & anticonvulsant (carbamazepine). Systemic toxicity: CNS & CV system.

  22. A- CNS: 1- All LAs at low conc: sleepiness, light headiness, visual & auditory disturbances & restlessness. Early symp: tongue numbness + metallic taste. Rare, but High plasma conc.: nystagmus & muscular twitching, then tonic-clonic convulsions. Followed by generalized CNS depression (apnea). Toxicity

  23. Convulsions: excessive LA level in ! bld. If large dose of LA is required: Rx pre-medication with BDZs prophylaxis. 2- For cocaine: widely abuse drug, severe CV toxicity; HTN, arrhythmia, & myocardial Failure. B- Neurotox: direct neuronal tox. With excessive high conc. Chloroprocaine & Lid are > neurotoxic than others in spinal anes.,: transient irritation (neuropathic symptoms).

  24. C- CVS: direct effect on ! hrt & smooth muscle & indirect effect on ! ANS. Depress strength of cardiac contraction, ECG changes & cause arteriolar dilatation;; hypotension. Bupivacaine is > cardiotoxic than other long-acting LA. Ropivaciane: CV & CNS tox, but < than Bupivacaine. Cocaine blocks Norepinephrine uptake: VC & HTN + cardiac arrhythmia & ischemia.

  25. D- Hematologic effects: Large dose of prilocaine: accumulation of Oxidizing Agent (o- toluidine) that convert Hg to metHg.;; cyanosis & chocolate-colored. Not recommended in infants. (Benzocaine can also cause metHg). Rx: IV methylene blue/ ascorbic acid. E- Allergic rxs: (Not with amides) Ester-type LAs are metabolized to P-ABA derivatives; allergic rxs.

More Related